Acquisition provides Ligand with the royalty rights to QARZIBA, a highly differentiated, commercial oncology drug marketed in 35 countries by global pharmaceutical company Recordati S.p.A.
NCIL was listed at Rs. 171 at an upper circuit premium of 90% over the fixed price band of Rs. 90
Laurus Labs receives EIR from USFDA for API facilities
Mahatma Gandhi Cancer Hospital & Research Institute has emerged as the leading provider of comprehensive cancer care in Viza
Ace Lab conducts 170 batches of testing per month and has capacity to do more than 250 batches per month
The Unit has now received Establishment Inspection Report classifying the facility as Voluntary Action Indicated
_256_384.jpg)
Glenmark released Picture Post Cards on World Vitiligo Day
Combined entity is better positioned to compete in increasingly competitive generics industry
Renews GMP certifications for India and Malaysia sites
Subscribe To Our Newsletter & Stay Updated
